NaaS Technology Maintains Strong ESG Momentum with '2' Rating and Improved Entity Score from Sustainable Fitch BEIJING, Dec. 12, 2024 /PRNewswire/ — NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS"… CISION PRNewswireDecember 12, 2024
Press ReleaseTech Trends That WON'T Happen in 2025: AI-RAN, Consumer Smart Glasses, Humanoids, and Semiconductor Onshoring – To Name a Few ABI Research’s 5th annual Trend Report identifies the 53 key technology trends… CISION PRNewswireDecember 12, 2024
Press ReleaseCore8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital – A Milestone in Preventive Healthcare and Technological Innovation in Long An… CISION PRNewswireDecember 12, 2024
Bamboo Rose Surpasses $2 Trillion in Retail Revenue Under Management, Marks Record-Breaking Growth in 2024 BOSTON, Dec. 12, 2024 /PRNewswire/ — Bamboo Rose, a global leader in retail… CISION PRNewswireDecember 12, 2024
aiMotive collaborates with Sony Semiconductor Solutions to revolutionize AD simulations BUDAPEST, Hungary, Dec. 12, 2024 /PRNewswire/ — aiMotive, a leading developer of simulation… CISION PRNewswireDecember 12, 2024
Press ReleasePorton Pharma Solutions and Aojin Life Sciences Announce Strategic Collaboration to Advance XDC Conjugate Drugs for Dual IND Filings in China and the U.S. CHONGQING, China, Dec. 12, 2024 /PRNewswire/ — Recently, Porton Pharma Solutions Ltd. ("Porton")… CISION PRNewswireDecember 12, 2024
CureGene Received Clinical Trial Approval in China for CG-0255 for Injection – A Novel Antiplatelet Therapy SHANGHAI, Dec. 12, 2024 /PRNewswire/ — CureGene Pharmaceutical ("CureGene"), a biotechnology company… CISION PRNewswireDecember 12, 2024
Press ReleaseSK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate SK bioscience’s first mRNA vaccine candidate is expected to enter clinical trials… CISION PRNewswireDecember 12, 2024
